Enzo Biochem, Inc.
ENZB
$0.5299
-$0.01-1.85%
OTC PK
| 04/30/2025 | 01/31/2025 | 10/31/2024 | 07/31/2024 | 04/30/2024 | |
|---|---|---|---|---|---|
| Net Income | 7.62% | 49.85% | 48.97% | -123.30% | 80.11% |
| Total Depreciation and Amortization | -5.64% | 19.10% | 18.15% | -34.32% | -47.99% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -145.07% | 232.56% | -82.07% | 104.34% | 120.71% |
| Change in Net Operating Assets | 86.96% | 77.04% | 32.93% | 82.03% | -115.99% |
| Cash from Operations | -12.51% | 77.33% | 32.78% | 93.63% | 43.37% |
| Capital Expenditure | -169.93% | -180.00% | -76.38% | 78.53% | 78.53% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -169.93% | -180.00% | 1,892.13% | -100.12% | 78.53% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -13.51% | 100.00% | 27.45% | 82.41% | 99.14% |
| Issuance of Common Stock | -- | -- | -- | -- | -- |
| Repurchase of Common Stock | 100.00% | -- | 65.10% | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 4.55% | -24,100.00% | 61.39% | 14.88% | -101.34% |
| Foreign Exchange rate Adjustments | 222.22% | -194.74% | 110.00% | 120.65% | -238.46% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -16.82% | 17.04% | 67.27% | -106.00% | -27.37% |